PLK-1 has also proven promising in other cancers, such as ovarian cancer, where a correlation between PLK-1 expression and clinical stage and grade has been established [35], and in melanoma, where an association with distant metastases has been demonstrated [36]. This evidence concerns the gene PLK1 and cancer.